saplin

UTI Small Cap Fund

UTI Small Cap Fund (Direct, Growth): saplin Score 5.7/10 (Weak) among 36 Small Cap funds. 3Y return 12.6% a year vs 14.1% category median, expense ratio 1.07%. Uneven returns hold this fund back. NAV ₹29.14 on 11 Nov 2026.

Loading the full analysis…

Questions about UTI Small Cap Fund

What is the expense ratio of UTI Small Cap Fund?

The Direct plan's total expense ratio is 1.07% a year, against a median of 0.91% for small cap funds. The Regular plan costs more because it pays a distributor's commission.

Who manages UTI Small Cap Fund?

Nitin Jain (since 1 Oct 2024).

What are the top holdings of UTI Small Cap Fund?

Acutaas Chemicals 3.15%, Navin Fluorine International 2.61%, Karur Vysya Bank 2.61%, The Great Eastern Shipping Company 1.93%, Marksans Pharma 1.92% of the portfolio, as of 31 Oct 2026.

What returns has UTI Small Cap Fund given?

1 year: 3.8% (category median 8.9%); 3 years: 12.6% a year (category median 14.1%); 5 years: 13.2% a year (category median 14.1%). Past returns do not predict future ones.

How big is UTI Small Cap Fund?

About ₹5,348 cr (AMFI's average for the latest quarter).

How does UTI Small Cap Fund score?

5.7 out of 10 (Weak) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.

More on UTI Small Cap